Cargando…
The effectiveness and safety of mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines among individuals with chronic kidney diseases
[Figure: see text]
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier, Inc., on behalf of the International Society of Nephrology.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367175/ https://www.ncbi.nlm.nih.gov/pubmed/35964798 http://dx.doi.org/10.1016/j.kint.2022.07.018 |
| _version_ | 1784765729594146816 |
|---|---|
| author | Cheng, Franco Wing Tak Fan, Min Wong, Carlos King Ho Chui, Celine Sze Ling Lai, Francisco Tsz Tsun Li, Xue Wan, Eric Yuk Fai Tang, Sydney Chi Wai Chan, Esther Wai Yin Wong, Ian Chi Kei |
| author_facet | Cheng, Franco Wing Tak Fan, Min Wong, Carlos King Ho Chui, Celine Sze Ling Lai, Francisco Tsz Tsun Li, Xue Wan, Eric Yuk Fai Tang, Sydney Chi Wai Chan, Esther Wai Yin Wong, Ian Chi Kei |
| author_sort | Cheng, Franco Wing Tak |
| collection | PubMed |
| description | [Figure: see text] |
| format | Online Article Text |
| id | pubmed-9367175 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Elsevier, Inc., on behalf of the International Society of Nephrology. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93671752022-08-11 The effectiveness and safety of mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines among individuals with chronic kidney diseases Cheng, Franco Wing Tak Fan, Min Wong, Carlos King Ho Chui, Celine Sze Ling Lai, Francisco Tsz Tsun Li, Xue Wan, Eric Yuk Fai Tang, Sydney Chi Wai Chan, Esther Wai Yin Wong, Ian Chi Kei Kidney Int Research Letter [Figure: see text] Published by Elsevier, Inc., on behalf of the International Society of Nephrology. 2022-10 2022-08-11 /pmc/articles/PMC9367175/ /pubmed/35964798 http://dx.doi.org/10.1016/j.kint.2022.07.018 Text en © 2022 Published by Elsevier, Inc., on behalf of the International Society of Nephrology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Research Letter Cheng, Franco Wing Tak Fan, Min Wong, Carlos King Ho Chui, Celine Sze Ling Lai, Francisco Tsz Tsun Li, Xue Wan, Eric Yuk Fai Tang, Sydney Chi Wai Chan, Esther Wai Yin Wong, Ian Chi Kei The effectiveness and safety of mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines among individuals with chronic kidney diseases |
| title | The effectiveness and safety of mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines among individuals with chronic kidney diseases |
| title_full | The effectiveness and safety of mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines among individuals with chronic kidney diseases |
| title_fullStr | The effectiveness and safety of mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines among individuals with chronic kidney diseases |
| title_full_unstemmed | The effectiveness and safety of mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines among individuals with chronic kidney diseases |
| title_short | The effectiveness and safety of mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines among individuals with chronic kidney diseases |
| title_sort | effectiveness and safety of mrna (bnt162b2) and inactivated (coronavac) covid-19 vaccines among individuals with chronic kidney diseases |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367175/ https://www.ncbi.nlm.nih.gov/pubmed/35964798 http://dx.doi.org/10.1016/j.kint.2022.07.018 |
| work_keys_str_mv | AT chengfrancowingtak theeffectivenessandsafetyofmrnabnt162b2andinactivatedcoronavaccovid19vaccinesamongindividualswithchronickidneydiseases AT fanmin theeffectivenessandsafetyofmrnabnt162b2andinactivatedcoronavaccovid19vaccinesamongindividualswithchronickidneydiseases AT wongcarloskingho theeffectivenessandsafetyofmrnabnt162b2andinactivatedcoronavaccovid19vaccinesamongindividualswithchronickidneydiseases AT chuicelineszeling theeffectivenessandsafetyofmrnabnt162b2andinactivatedcoronavaccovid19vaccinesamongindividualswithchronickidneydiseases AT laifranciscotsztsun theeffectivenessandsafetyofmrnabnt162b2andinactivatedcoronavaccovid19vaccinesamongindividualswithchronickidneydiseases AT lixue theeffectivenessandsafetyofmrnabnt162b2andinactivatedcoronavaccovid19vaccinesamongindividualswithchronickidneydiseases AT wanericyukfai theeffectivenessandsafetyofmrnabnt162b2andinactivatedcoronavaccovid19vaccinesamongindividualswithchronickidneydiseases AT tangsydneychiwai theeffectivenessandsafetyofmrnabnt162b2andinactivatedcoronavaccovid19vaccinesamongindividualswithchronickidneydiseases AT chanestherwaiyin theeffectivenessandsafetyofmrnabnt162b2andinactivatedcoronavaccovid19vaccinesamongindividualswithchronickidneydiseases AT wongianchikei theeffectivenessandsafetyofmrnabnt162b2andinactivatedcoronavaccovid19vaccinesamongindividualswithchronickidneydiseases AT chengfrancowingtak effectivenessandsafetyofmrnabnt162b2andinactivatedcoronavaccovid19vaccinesamongindividualswithchronickidneydiseases AT fanmin effectivenessandsafetyofmrnabnt162b2andinactivatedcoronavaccovid19vaccinesamongindividualswithchronickidneydiseases AT wongcarloskingho effectivenessandsafetyofmrnabnt162b2andinactivatedcoronavaccovid19vaccinesamongindividualswithchronickidneydiseases AT chuicelineszeling effectivenessandsafetyofmrnabnt162b2andinactivatedcoronavaccovid19vaccinesamongindividualswithchronickidneydiseases AT laifranciscotsztsun effectivenessandsafetyofmrnabnt162b2andinactivatedcoronavaccovid19vaccinesamongindividualswithchronickidneydiseases AT lixue effectivenessandsafetyofmrnabnt162b2andinactivatedcoronavaccovid19vaccinesamongindividualswithchronickidneydiseases AT wanericyukfai effectivenessandsafetyofmrnabnt162b2andinactivatedcoronavaccovid19vaccinesamongindividualswithchronickidneydiseases AT tangsydneychiwai effectivenessandsafetyofmrnabnt162b2andinactivatedcoronavaccovid19vaccinesamongindividualswithchronickidneydiseases AT chanestherwaiyin effectivenessandsafetyofmrnabnt162b2andinactivatedcoronavaccovid19vaccinesamongindividualswithchronickidneydiseases AT wongianchikei effectivenessandsafetyofmrnabnt162b2andinactivatedcoronavaccovid19vaccinesamongindividualswithchronickidneydiseases |